Short answer: Verify state licensure where you are located, transparent pricing/cancellation/informed consent before billing, and whether products are compounded vs FDA-approved — a 2025 FTC case against NextMed shows exactly what goes wrong when providers skip these basics.
Choosing a longevity telehealth provider isn't just about price and product selection — it's also about licensing, prescribing rules, and consumer protections that most people never think to check. A recent, real FTC enforcement case against a telehealth weight-loss company shows exactly what can go wrong when a provider cuts corners on these basics. Here's what's actually worth verifying before you start.
The Foundational Rule: Where the Patient Is Located Matters
A foundational fact worth understanding before evaluating any longevity telehealth provider: state medical boards consider the practice of medicine to occur where the patient is physically located, not where the prescribing clinician is based.[1] That means a provider generally must hold a license in your specific state to legally treat you.
One of the most important things to verify is whether a provider's clinicians are actually licensed in your state, or are operating under a valid licensure exception, interstate compact, or telehealth-specific registration recognized by your state's medical board.
The Standard of Care Doesn't Change Just Because It's Online
Standards of care are legally required to be the same for a telehealth visit as an in-person one — state regulations and professional guidance consistently affirm that a physician has the same duty to exercise reasonable care, diligence, and skill regardless of the format care is delivered in.[2]A trustworthy telehealth practice should reflect that: proper identity verification, documented informed consent, complete medical records, and adherence to state and federal confidentiality requirements — the same standards you'd expect from an in-person clinic.
If Controlled Substances Are Involved: The Ryan Haight Act
If a longevity program includes prescribing any DEA-scheduled controlled substance, there's a specific federal framework worth knowing about. Under the Ryan Haight Act, a remote prescriber generally must have either conducted at least one in-person medical evaluation of the patient, or be operating under a specific telemedicine exception recognized under federal law — and the prescriber must be DEA-registered both where they're located and in every state where their patients are physically located.
As of late 2025, the DEA has extended flexibilities allowing registered practitioners to prescribe certain Schedule II–V controlled medications via audio-video telemedicine without a prior in-person evaluation, provided the encounter meets specific federal conditions.[3]This is an area that periodically changes, so it's worth verifying a provider's current compliance approach directly rather than assuming it's permanently settled.
A Real Case Study in What Can Go Wrong
This isn't a hypothetical risk. In December 2025, the FTC gave final approval to an enforcement order against telemedicine company NextMed and its two principals over their GLP-1 weight-loss programs.[4]The FTC's findings, drawn directly from its own case record, are worth knowing as a checklist of exactly what a legitimate provider should not be doing:
- Charging monthly subscription costs ($138–$188) without properly disclosing that the price didn't actually include the medications themselves, or required lab work and consultations
- Making unsubstantiated claims about typical weight-loss results
- Using fake testimonials and unfairly manipulating consumer reviews
- Failing to obtain express informed consent before charging consumers or initiating recurring debits
- Failing to process cancellation and refund requests in a timely manner
The final order required NextMed and its principals to pay $150,000 — expected to go toward consumer refunds — and imposed a set of forward-looking requirements that double as a genuinely useful checklist for evaluating any telehealth provider: obtain informed consent before billing, clearly disclose refund and cancellation terms beforea consumer pays, and provide a simple, actual mechanism for consumers to request cancellations or refunds. A legitimate provider should already have all of this in place voluntarily — you shouldn't need an FTC order to get it.[4]
Understanding Compounded vs. FDA-Approved Products
Because many longevity treatments — peptides, NAD+, and hormone therapies among them — are compounded rather than FDA-approved products, a responsible provider should be transparent about which one you're actually getting. Compounded drugs are exempt from the FDA's premarket safety and efficacy review and manufacturing standards that apply to approved drugs.[5]
Worth checking specifically: is the pharmacy a 503A (patient-specific prescription, primarily state-regulated) or 503B (outsourcing facility, subject to full FDA manufacturing standards and routine inspection) compounder? This affects the actual level of regulatory oversight the product has received. And since FDA guidance states compounded drugs "should only be used to meet the needs of patients whose medical needs cannot be met by an FDA-approved drug," a provider defaulting to compounded versions of treatments that have an approved alternative available is a reasonable thing to ask about directly.
Verify Independently, Not Just via the Provider's Website
State licensure and telehealth practice rules vary meaningfully and change periodically, and federal DEA telemedicine flexibilities for controlled substances remain subject to further extension or expiration. The most reliable approach: verify a clinician's current license status directly with your state medical board, rather than relying solely on claims made on the provider's own website.
The Bottom Line
Most of what separates a trustworthy longevity telehealth provider from a problematic one isn't about which compounds they offer — it's about the basics: proper licensing in your state, transparent pricing and cancellation terms, informed consent before billing, and honesty about whether you're getting a compounded or FDA-approved product. The NextMed case is a useful, concrete reminder that these aren't abstract concerns — they're exactly the issues regulators actually pursue when a provider gets them wrong.
If you're comparing options, RENVA's Longevity Shop by Treatment comparison tracks exactly these kinds of transparency factors — pricing clarity, cancellation policy, and pharmacy disclosure — across providers side by side.
Sources
- Licensure & Telehealth — Issue Brief — American Medical Association ama-assn.org
- Telehealth Practice Standards With Emphasis on the United States — PMC (National Institutes of Health) pmc.ncbi.nlm.nih.gov
- DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care — U.S. Drug Enforcement Administration dea.gov
- FTC Approves Final Order against Telehealth Provider NextMed Over Charges It Used Deceptive Advertising Claims to Sell GLP-1 Weight-Loss Programs — Federal Trade Commission ftc.gov
- Compounding Laws and Policies — U.S. Food and Drug Administration fda.gov
Frequently Asked Questions
Does a telehealth provider need to be licensed in my state?
Yes, generally. State medical boards consider the practice of medicine to occur where the patient is located, so a provider typically needs to be licensed (or operating under a recognized exception) in your specific state.
What should a legitimate telehealth provider disclose before I pay?
Full, clear pricing (including any costs not included in a subscription price), refund and cancellation terms, and informed consent before billing. A recent FTC case against NextMed specifically targeted providers who failed at these basics.
How do I verify a telehealth clinician's license?
Check directly with your state's medical board rather than relying solely on the provider's own website claims — licensure rules and status can change.